{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:36:21Z","timestamp":1761989781174},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen Innovation and Technology Commission Foundation","award":["JCYJ20230807111302005"],"award-info":[{"award-number":["JCYJ20230807111302005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40257-024-00873-0","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:31:22Z","timestamp":1720189882000},"page":"857-859","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study"],"prefix":"10.1007","volume":"25","author":[{"given":"Yu","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linya","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianmeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"873_CR1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2147\/CCID.S407813","volume":"16","author":"L Potestio","year":"2023","unstructured":"Potestio L, Camela E, Cacciapuoti S, et al. Biologics for the management of erythrodermic psoriasis: an updated review. Clin Cosmet Investig Dermatol. 2023;16:2045\u201359.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"873_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","volume":"62","author":"M Rosenbach","year":"2010","unstructured":"Rosenbach M, Hsu S, Korman NJ, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(4):655\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"873_CR3","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1080\/14712598.2022.2128669","volume":"22","author":"S Dogra","year":"2022","unstructured":"Dogra S, Mehta H. Biological treatment for erythrodermic psoriasis. Expert Opin Biol Ther. 2022;22(12):1531\u201343.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"873_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/jcm8060770","volume":"8","author":"G Damiani","year":"2019","unstructured":"Damiani G, Pacifico A, Russo F, et al. Use of secukinumab in a cohort of erythrodermic psoriatic patients: a pilot study. J Clin Med. 2019;8(6):770.","journal-title":"J Clin Med"},{"issue":"7","key":"873_CR5","doi-asserted-by":"publisher","first-page":"e574","DOI":"10.1111\/jdv.18069","volume":"36","author":"G Avallone","year":"2022","unstructured":"Avallone G, Cariti C, Dapavo P, et al. Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis. J Eur Acad Dermatol Venereol. 2022;36(7):e574\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"873_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/bjd.18174","volume":"181","author":"Y Lo","year":"2019","unstructured":"Lo Y, Tsai TF. Clinical experience of ixekizumab in the treatment of patients with history of chronic erythrodermic psoriasis who failed secukinumab: a case series. Br J Dermatol. 2019;181(5):1106\u20137.","journal-title":"Br J Dermatol"},{"issue":"6","key":"873_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1684\/ejd.2018.3437","volume":"28","author":"F Ye","year":"2018","unstructured":"Ye F, Gui X, Wu C, Yu X, Jin H. Severity evaluation and prognostic factors in erythrodermic psoriasis. Eur J Dermatol. 2018;28(6):851\u20133.","journal-title":"Eur J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-024-00873-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00873-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T11:32:37Z","timestamp":1724844757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-024-00873-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1007\/s40257-024-00873-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"type":"print","value":"1175-0561"},{"type":"electronic","value":"1179-1888"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"29 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was partially supported by Shenzhen Innovation and Technology Commission Foundation (grant no. JCYJ20230807111302005).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Anonymized data will be available upon request by qualifying researchers.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"All study documents and procedures were approved by the appropriate institutional review boards\/ethics committees at each study site. The study was conducted in compliance with the ethical principles originating in or derived from the Declaration of Helsinki and in compliance with all International Council for Harmonization Good Clinical Practice Guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Y.L. (first author): conceptualization, methodology, software, investigation, writing\u2014original draft, writing\u2014review and editing; X.Y.W.: methodology, investigation, project administration; L.Y.N.: validation, investigation, resources; Y.H.L.: validation, investigation; T.M.Y.: resources, investigation; D.J.D.: data curation, supervision, project administration; and Z.Y.Z. (corresponding author): conceptualization, data curation, writing\u2014review and editing, visualization, funding acquisition. All authors have read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}